BioCardia, Inc. [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today reported financial results for the first ...

Company Posts Best Q1 Fiscal Period in Its History with $2.1 Million in RevenueROSEVILLE, MN, May 15, 2026 (GLOBE NEWSWIRE) -- SecureTech ...

IDFC FIRST Bank unveiled the FD-backed Business Multiplier Metal Credit Card for founders, entrepreneurs and business owners.

INmune Bio Inc. (NASDAQ: INMB), a clinical-stage biotechnology company developing therapies that target innate immune dysfunction, today announced that results from its Phase 2 MINDFuL trial in ...

A growing drug war has erupted over kratom sales. The family of a Thousand Oaks man who died after using it is suing a ...

Explore the transformation of MBA placements into an ongoing journey, emphasizing adaptability, technology, and real-world ...

Conference call to discuss financial and operational results scheduled for Friday, May 15 at 8:30 a.m. U.S. Eastern Time ...

Sports leagues once regularly went after fans who posted highlights (or lowlights) online without special permission. Now, ...

The legal architecture for AI governance is no longer about policy adoption but about whether an organization can produce evidence that traces ...

Earlier today, Elutia released financial results for the first quarter ended March 31, 2026. A copy of the press release is ...

Net revenue -- $57.5 million, down 10% year over year due to a 15% decrease in total orders and higher return rates, partly ...

Continued adoption of Shield technology supports the Company's expected transition to profitability in fiscal 2026 ...